Salivary flow rate, subjective oral dryness and dental caries 5 years after haematopoietic cell transplantation.
Cancer survivors
Dental caries
Haematopoietic stem cell transplantation
Long term adverse effects
Xerostomia
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
received:
15
03
2024
accepted:
23
08
2024
medline:
11
9
2024
pubmed:
11
9
2024
entrez:
10
9
2024
Statut:
epublish
Résumé
The aim of this study was to describe salivary flow rate, subjective oral dryness and dental caries 5 years post haematopoietic cell transplantation (HCT). HCT survivors of a previous longitudinal observational cohort study in the Netherlands (the H-OME study) were invited to participate in this additional follow-up after 5 years (the HOME2 study). During the additional follow-up appointment, stimulated (SWS) and unstimulated whole saliva (UWS) was collected, participants rated subjective oral dryness on a 0 - 10 scale, and caries lesions were assessed. Furthermore, dental records, including treatments and radiographs, were requested for the 5 years preceding and the 5 years following transplantation. Paired t-tests were performed to determine changes in UWS and SWS flow rates and subjective oral dryness from pre-HCT, and to compare the number of caries-related dental treatments (restorations, endodontic treatments or extractions) before and after HCT. Hyposalivation of UWS (< 0.2 mL/min) and SWS (< 0.7 mL/min) at 3 and 12 months, was used to explore the predictive potential of hyposalivation on a high dental treatment need (> 3 treatments) over the 5 years post-HCT. Five years post-HCT, 39 HCT survivors were included. The mean UWS flow rate was 0.36 mL/min (SD 0.26) and the mean SWS flow rate 1.02 (SD 0.57); survivors were diagnosed with a median of 0 dentine lesions (range 0 - 12) and 73% reported a subjective oral dryness score ≥ 1. Survivors underwent a median of 3 (range 0 - 20) dental treatments during the 5 years following transplantation. The mean difference in UWS 5 years post-HCT compared to pre-HCT was 0.03 (95% CI: -0.07 - 10.12), the mean difference for SWS was -0.18 (95% CI: -0.45 - 0.08) and for subjective oral dryness 1.2 (95% CI: 0.2 - 2.1). In the 5 years post-HCT, non-significantly more treatments were performed compared to the 5 years pre-HCT (mean difference: 0.5, 95%CI: -1.2 - 2.2). Seventy eight percent of patients with hyposalivation of SWS at 12 months had a high dental treatment need, compared with 38% with no hyposalivation. Five years post-HCT, mean UWS and SWS flow rates were not significantly different from pre-HCT levels but subjective oral dryness scores were elevated.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this study was to describe salivary flow rate, subjective oral dryness and dental caries 5 years post haematopoietic cell transplantation (HCT).
METHODS
METHODS
HCT survivors of a previous longitudinal observational cohort study in the Netherlands (the H-OME study) were invited to participate in this additional follow-up after 5 years (the HOME2 study). During the additional follow-up appointment, stimulated (SWS) and unstimulated whole saliva (UWS) was collected, participants rated subjective oral dryness on a 0 - 10 scale, and caries lesions were assessed. Furthermore, dental records, including treatments and radiographs, were requested for the 5 years preceding and the 5 years following transplantation. Paired t-tests were performed to determine changes in UWS and SWS flow rates and subjective oral dryness from pre-HCT, and to compare the number of caries-related dental treatments (restorations, endodontic treatments or extractions) before and after HCT. Hyposalivation of UWS (< 0.2 mL/min) and SWS (< 0.7 mL/min) at 3 and 12 months, was used to explore the predictive potential of hyposalivation on a high dental treatment need (> 3 treatments) over the 5 years post-HCT.
RESULTS
RESULTS
Five years post-HCT, 39 HCT survivors were included. The mean UWS flow rate was 0.36 mL/min (SD 0.26) and the mean SWS flow rate 1.02 (SD 0.57); survivors were diagnosed with a median of 0 dentine lesions (range 0 - 12) and 73% reported a subjective oral dryness score ≥ 1. Survivors underwent a median of 3 (range 0 - 20) dental treatments during the 5 years following transplantation. The mean difference in UWS 5 years post-HCT compared to pre-HCT was 0.03 (95% CI: -0.07 - 10.12), the mean difference for SWS was -0.18 (95% CI: -0.45 - 0.08) and for subjective oral dryness 1.2 (95% CI: 0.2 - 2.1). In the 5 years post-HCT, non-significantly more treatments were performed compared to the 5 years pre-HCT (mean difference: 0.5, 95%CI: -1.2 - 2.2). Seventy eight percent of patients with hyposalivation of SWS at 12 months had a high dental treatment need, compared with 38% with no hyposalivation.
CONCLUSIONS
CONCLUSIONS
Five years post-HCT, mean UWS and SWS flow rates were not significantly different from pre-HCT levels but subjective oral dryness scores were elevated.
Identifiants
pubmed: 39256697
doi: 10.1186/s12903-024-04804-7
pii: 10.1186/s12903-024-04804-7
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1058Informations de copyright
© 2024. The Author(s).
Références
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813–26.
doi: 10.1056/NEJMra052638
pubmed: 16641398
Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 2016;51(6):778–85.
doi: 10.1038/bmt.2016.18
pubmed: 26901703
pmcid: 4889523
Granot N, Storb R. History of hematopoietic cell transplantation: challenges and progress. Haematologica. 2020;105(12):2716–29.
doi: 10.3324/haematol.2019.245688
pubmed: 33054108
pmcid: 7716373
Brand HS, Bots CP, Raber-Durlacher JE. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;207(9):E17; discussion 428-9.
doi: 10.1038/sj.bdj.2009.977
pubmed: 19893563
Hull KM, Kerridge I, Schifter M. Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant. 2012;47(2):265–70.
doi: 10.1038/bmt.2011.63
pubmed: 21441960
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039–60.
doi: 10.1007/s00520-010-0827-8
pubmed: 20237805
Ferreira MH, Mello Bezinelli L, de Paula EF, Lopes RM, Pereira AZ, Hamerschlack N, Corrêa L. Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study. Support Care Cancer. 2020;28(3):1277–87.
doi: 10.1007/s00520-019-04922-x
pubmed: 31236700
Bulthuis MS, van Gennip LLA, Thomas RZ, Bronkhorst EM, Laheij A, Raber-Durlacher JE, et al. The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study. Clin Oral Investig. 2023;27(12):7369–81.
Uutela P, Passweg J, Halter J, Gerull S, Weiger R, Mauramo E, et al. Common oral diseases, hyposalivation and survival post-HSCT, a longitudinal study. Eur J Haematol. 2019;103(4):300–6.
doi: 10.1111/ejh.13283
pubmed: 31240771
Boer CC, Correa ME, Tenuta LM, Souza CA, Vigorito AC. Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components. Support Care Cancer. 2015;23(9):2561–7.
doi: 10.1007/s00520-015-2613-0
pubmed: 25652148
Daikeler T, Mauramo M, Rovo A, Stern M, Halter J, Buser A, et al. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant. 2013;48(7):988–93.
doi: 10.1038/bmt.2012.260
pubmed: 23292241
Arduino PG, Gambino A, Giaccone L, Suria M, Carbone M, Carrozzo M, et al. Oral health status after hematopoietic stem cell transplantations: Outcomes from an adult Italian population. Spec Care Dentist. 2022;42(6):585–91.
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant. 2010;16(10):1362–9.
doi: 10.1016/j.bbmt.2010.03.023
pubmed: 20353829
pmcid: 2910178
Sreebny LM, Xerostomia VA. 1. Relationship to Other Oral Symptoms and Salivary-Gland Hypofunction. Oral Surg Oral Med O. 1988;66(4):451–8.
doi: 10.1016/0030-4220(88)90268-X
Bulthuis MS, van Gennip LLA, Bronkhorst EM, Blijlevens NMA, Huysmans M, van Leeuwen SJM, Thomas RZ. The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress. Support Care Cancer. 2023;31(8):449.
doi: 10.1007/s00520-023-07921-1
pubmed: 37421511
pmcid: 10329604
Dawes C, Pedersen AML, Villa A, Ekströme J, Proctor GB, Vissink A, et al. The functions of human saliva: A review sponsoredby the World Workshop on Oral Medicine VI. Arch Oral Biol. 2015;60:863–74.
doi: 10.1016/j.archoralbio.2015.03.004
pubmed: 25841068
Leone CW, Oppenheim FG. Physical and chemical aspects of saliva as indicators of risk for dental caries in humans. J Dent Educ. 2001;65(10):1054–62.
doi: 10.1002/j.0022-0337.2001.65.10.tb03449.x
pubmed: 11699977
Bulthuis MS, van Gennip LLA, Thomas RZ, Bronkhorst EM, Laheij A, Raber-Durlacher JE, et al. Caries Progression after Haematopoietic Stem Cell Transplantation and the Role of Hyposalivation. Caries Res. 2022;56(3):187–96.
doi: 10.1159/000525599
pubmed: 35724637
van Leeuwen SJM, Proctor GB, Laheij A, Potting CMJ, Smits O, Bronkhorst EM, et al. Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021;56(6):1381–90.
doi: 10.1038/s41409-020-01185-7
pubmed: 33420397
pmcid: 8189903
van Leeuwen SJM, Proctor GB, Staes A, Laheij A, Potting CMJ, Brennan MT, et al. The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach. BMC Oral Health. 2023;23(1):460.
doi: 10.1186/s12903-023-03190-w
pubmed: 37420206
pmcid: 10329372
Laheij A, Raber-Durlacher JE, Koppelmans RGA, Huysmans M, Potting C, van Leeuwen SJM, et al. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019;9(1):16929.
doi: 10.1038/s41598-019-53073-w
pubmed: 31729407
pmcid: 6858439
Laheij A, Rozema FR, Brennan MT, von Bultzingslowen I, van Leeuwen SJM, Potting C, et al. Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients. Microorganisms. 2022;10(4):734.
Ismail AI, Sohn W, Tellez M, Amaya A, Sen A, Hasson H, Pitts NB. The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol. 2007;35(3):170–8.
doi: 10.1111/j.1600-0528.2007.00347.x
pubmed: 17518963
Ekstrand KR, Gimenez T, Ferreira FR, Mendes FM, Braga MM. The International Caries Detection and Assessment System - ICDAS: A Systematic Review. Caries Res. 2018;52(5):406–19.
doi: 10.1159/000486429
pubmed: 29518788
Navazesh M, Kumar SK, University of Southern California School of D. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008;139 Suppl:35S–40S.
doi: 10.14219/jada.archive.2008.0353
pubmed: 18460678
Sreebny LM. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol. 1988;66(4):451–8.
Proctor GB, Shaalan AM. Disease-Induced Changes in Salivary Gland Function and the Composition of Saliva. J Dent Res. 2021;100(11):1201–9.
doi: 10.1177/00220345211004842
pubmed: 33870742
Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94(4):547–54.
doi: 10.1177/0022034515570942
pubmed: 25740857
pmcid: 4485216
Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, et al. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Support Care Cancer. 2016;24(9):3915–24.
doi: 10.1007/s00520-016-3216-0
pubmed: 27113466
Pedersen AML, Sorensen CE, Proctor GB, Carpenter GH, Ekstrom J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730–46.
doi: 10.1111/joor.12664
pubmed: 29878444
Laaksonen M, Ramseier AM, Rovo A, Jensen SB, Raber-Durlacher JE, Zitzmann NU, Waltimo T. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. J Dent Res. 2011;90(10):1177–82.
doi: 10.1177/0022034511414156
pubmed: 21734227
Aliko A, Wolff A, Dawes C, Aframian D, Proctor G, Ekstrom J, et al. World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(2):185–206.
doi: 10.1016/j.oooo.2014.10.027
pubmed: 25861957
Laske M, Opdam NJ, Bronkhorst EM, Braspenning JC, Huysmans MC. Longevity of direct restorations in Dutch dental practices. Descriptive study out of a practice based research network. J Dent. 2016;46:12–7.
doi: 10.1016/j.jdent.2016.01.002
pubmed: 26790901
Eltahlah D, Lynch CD, Chadwick BL, Blum IR, Wilson NHF. An update on the reasons for placement and replacement of direct restorations. J Dent. 2018;72:1–7.
doi: 10.1016/j.jdent.2018.03.001
pubmed: 29522787
Mejare I, Stenlund H, Zelezny-Holmlund C. Caries incidence and lesion progression from adolescence to young adulthood: a prospective 15-year cohort study in Sweden. Caries Res. 2004;38(2):130–41.
doi: 10.1159/000075937
pubmed: 14767170
Havsed K, Hansel Petersson G, Isberg PE, Pigg M, Svensater G, Foresight Research C, Rohlin M. Multivariable prediction models of caries increment: a systematic review and critical appraisal. Syst Rev. 2023;12(1):202.
doi: 10.1186/s13643-023-02298-y